THE NEW YORK TIMES: OpenAI trial starts with two very different tales of a company’s early years – Oxysage

THE NEW YORK TIMES: OpenAI trial starts with two very different tales of a company’s early years

On the first day of testimony in a landmark trial between Elon Musk and OpenAI CEO Sam Altman, two notably different tales were offered of how OpenAI evolved.

About admin